The Valley Desk

ArticleDrugs - real world outcomesPublished

Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Drugs - real world outcomes
Published
PubMed ID
39828878
PubMed Central ID
PMC11829853
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal